Pi-Cardia today announced the first commercial procedures with its ShortCut leaflet modification device for enabling heart ...

Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedures with ShortCut™ - the world's first ...

Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedures with ShortCuttm - the world's first ...

First dedicated leaflet modification solution to enable TAVR in patients at risk of coronary obstruction Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treati ...

Endologix LLC, a privately held global medical device company specializing in innovative therapies for vascular disease, is ...

A review highlights how, amid shifts in care delivery, US veterans can still find high quality at their VA medical center.

The early trend, which is likely to continue for the rest of 2025, reflects a shift to mitigate risk amid market ...